Teva Pharmaceuticals
TEVA
TEVA
818 hedge funds and large institutions have $30.6B invested in Teva Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 260 increasing their positions, 327 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
818
Holders Change
-3
Holders Change %
-0.37%
% of All Funds
22.06%
Holding in Top 10
47
Holding in Top 10 Change
-23
Holding in Top 10 Change %
-32.86%
% of All Funds
1.27%
New
87
Increased
260
Reduced
327
Closed
82
Calls
$692M
Puts
$508M
Net Calls
+$184M
Net Calls Change
-$184M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
$3.84B |
| 2 |
SC
Sculptor Capital
New York
|
$216M |
| 3 |
GCM
Glenview Capital Management
New York
|
$168M |
| 4 |
SIG
Senator Investment Group
New York
|
$136M |
| 5 |
PC
Paulson & Co
New York
|
$120M |
